Skip to main content
Journal of Diabetes Investigation logoLink to Journal of Diabetes Investigation
. 2015 Apr 2;6(5):567–570. doi: 10.1111/jdi.12340

Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus

Naoki Sakane 1,*, Kazuhiko Kotani 1,2, Kokoro Tsuzaki 1, Masami Nishi 1,3, Kaoru Takahashi 1,4, Takashi Murata 5, Kazunori Yamada 5, Kentaro Okazaki 6, Katsuyuki Yanagisawa 7, Kenichi Yamada 8, Nobuichi Kuribayashi 9, Yasuo Totsuka 10, Toru Hiyoshi 11, Motoji Naka 12, Masatake Sugimoto 13, Yuji Aoki 14, Masako Waki 15, Miyuki Furuya 16, Haruko Kitaoka 17, Mariko Oishi 18, Ikki Shimizu 19, Hiroaki Miyaoka 20, Akira Okada 3, Toshikazu Yamamoto 21
PMCID: PMC4578497  PMID: 26417415

Abstract

The aim of the present study was to investigate the prevalence of fear of hypoglycemia, in association with severe hypoglycemia and social factors, in insulin-treated patients with type 2 diabetes mellitus. A questionnaire survey on hypoglycemia and patient–physician communication was carried out in 355 patients with insulin-treated type 2 diabetes mellitus patients at 16 hospitals and clinics. A fear of hypoglycemia was reported by 27.7% of patients. A stepwise logistic regression analysis found that severe hypoglycemia during the past 1 year was a significant determinant of fear of hypoglycemia (odds ratio 2.16, 95% confidence interval 1.06–4.41; P = 0.034), and age (odds ratio 1.02, 95% confidence interval 1.00–1.05, P = 0.038) and living alone (odds ratio 1.93, 95% confidence interval 1.00–3.73, P < 0.05) were significantly higher in patients with fear of hypoglycemia than in those without it.

Keywords: Fear, Hypoglycemia, Insulin, Type 2 diabetes

Introduction

The incidence of type 2 diabetes mellitus is increasing worldwide, and the International Diabetes Federation has warned of the sociomedical impact1. Although glycemic control is required for managing type 2 diabetes mellitus, hypoglycemia with antihyperglycemic agents, especially insulin, limits the management of type 2 diabetes mellitus2. Hypoglycemia is also a burden reducing the quality of life of type 2 diabetes mellitus patients3. Severe hypoglycemia (SH) can increase the fear of future hypoglycemic events. To try to reduce hypoglycemic events, many patients with type 2 diabetes mellitus maintain their blood glucose levels with a ‘safety margin’ (i.e., at higher than recommended values) and maintain hyperglycemia4. Thus, further studies are required regarding fear of hypoglycemia in patients with type 2 diabetes mellitus. The aim of the present study was to investigate the prevalence of fear of hypoglycemia, in association with SH and social factors, in insulin-treated patients with type 2 diabetes mellitus.

Materials and methods

Participants

A cross-sectional survey was carried out across Japan, in which 840 questionnaires were handed out by doctors and sent by mail to research centers in Kyoto Medical Center. The questionnaires were completed anonymously. Overall, the response rate was 75% (n = 630). Type 1 diabetes mellitus (n = 219) and incomplete questionnaires (n = 56) were excluded.

We recruited 355 adult patients with type 2 diabetes mellitus at 16 hospitals and clinics nationwide in Japan. Inclusion criteria were: (i) aged over 20 years; (ii) type 2 diabetes mellitus; (iii) insulin treatment; and (iv) regularly attended the hospitals and clinics surveyed. Exclusion criteria were: (i) children and young patients aged under 20 years, and (ii) type 1 diabetes mellitus.

Ethics

The study was approved by the ethical committee at National Hospital Organization Kyoto Medical Center.

Study Measures

Clinical data, such as the insulin regimen and diabetic complications, were collected from the patients' physicians. The self-administrated questionnaire was distributed and retrieved between 2006 and 2010. Patients completed the questionnaire to assess hypoglycemia and the fear of it. Hypoglycemia was defined as blood sugar ≤50 mg/dL (2.8 mmol/L) or symptoms of dizziness, blurry vision, confusion and/or sweating that the patient was able to resolve without assistance according to the definition of Treatment Guide for Diabetes of the Japan Diabetes Society5,6. Similar symptoms that required external assistance were defined as SH7,8. Fear of hypoglycemia was assessed using a five-point Likert scale (scored as 1–5)9. The presence of fear of hypoglycemia was defined as the highest quintile. Favorable glycemic control to prevent diabetic complications was defined as hemoglobin A1c <7% (52 mmol/mol)10 according to the ‘Kumamoto declaration 2013.’ Current smoking and alcohol drinking were recorded as previously shown11. We used participants' responses to a question regarding the marital status, ‘What is your marital status (married or unmarried)?’12 and ‘What is your life status (live alone or with someone)?’.

Statistical Analysis

Data are presented as the mean ± standard deviation or percentage. Student's t-test or the χ2-test were used to compare data between the groups. Univariate logistic testing was used to screen for significant determinants of the outcomes. Factors with an associated P-value of less than 0.05 were entered into a stepwise backwards conditional multivariable logistic regression procedure. A stepwise logistic regression analysis model was used to identify significant determinants of the outcomes. The Statistical Package for the Social Sciences (spss version 20.0, IBM Corp., Armonk, NY, USA) was used for these analyses. A two-tailed P-value <0.05 was considered significant.

Results

A fear of hypoglycemia was reported by 27.7% of patients. Age, living alone, the diabetes duration and percentage of SH were significantly higher in patients with fear of hypoglycemia than in those without it. There were no significant differences in clinical characteristics, such as the prevalence of hypoglycemia, insulin regimen and diabetic complications, between the patients with and without fear of hypoglycemia (Table 1).

Table 1.

Clinical data of patients with and without fear of hypoglycemia

Variables With fear of hypoglycemia (n = 98) Without fear of hypoglycemia (n = 257) P-value
Age (years) 64.6 (11.9) 61.0 (11.8) 0.011
Male (%) 60.2 58.8 0.804
Current smoking (%) 23.5 21.4 0.674
Alcohol drinking (%) 15.3 12.1 0.416
Living alone (%) 19.4 10.5 0.026
Married (%) 78.6 83.3 0.303
Diabetes duration (years) 18.2 (11.1) 15.4 (8.9) 0.030
Injection regimen
 1 time per day 7.2 6.2 0.702
 2 times per day 37.1 37.0
 3 times per day 34.0 29.6
 ≥4 times per day 21.6 27.2
Daily insulin dose (units) 0.44 (0.21) 0.44 (0.23) 0.931
Sulfonylureas (%) 17.0 11.4 0.166
Biguanides (%) 20.0 23.6 0.479
Alpha-glucosidase inhibitors (%) 20.0 16.7 0.469
Thiazolidine (%) 3.2 5.3 0.405
Body mass index (kg/m2) 24.4 (3.8) 24.5 (4.4) 0.763
HbA1c (%) 7.6 (1.3) 7.6 (1.2) 0.850
Patients with HbA1c <7% 68.4 63.5 0.394
Retinopathy (%) 51.0 45.3 0.333
Nephropathy (%) 43.9 46.7 0.634
Neuropathy (%) 36.5 46.6 0.090
Atherosclerosis (%) 21.6 20.1 0.744
Hypoglycemia (times per month) 1.1 (2.0) 1.2 (1.9) 0.542
SH during the past 1 year (%) 17.3 7.8 0.008
Carrying diabetic data book (%) 38.5 32.9 0.325

Data are means (standard deviation) or percentage. HbA1c, hemoglobin A1c; SH, severe hypoglycemia.

In univariate analysis, age (odds ratio [OR] 1.03, 95% confidence interval [CI] 1.01–1.05, P = 0.011), living alone (OR 2.05, 95% CI 1.08–3.89, P = 0.028), diabetes duration (OR 1.03, 95% CI 1.01–1.06, P = 0.017) and SH during the past 1 year (OR 2.49, 95% CI 1.24–4.98, P = 0.010) were significantly correlated with a fear of hypoglycemia. Non-severe hypoglycemia was not associated with a fear of hypoglycemia. A stepwise logistic regression analysis found that SH during the past 1 year was a significant determinant of fear of hypoglycemia (OR 2.16, 95% CI 1.06–4.41, P = 0.034), age (OR 1.02, 95% CI 1.00–1.05, P = 0.038) and living alone (OR 1.93, 95% CI 1.00–3.73, P < 0.05).

Discussion

The present study showed that SH during the past 1 year was associated with a fear of hypoglycemia in insulin-treated adult patients with type 2 diabetes mellitus, a specific population that is required to achieve good glycemic control using insulin therapy. Similar results were reported in previous studies of children with type 1 diabetes mellitus13,14 and patients with type 2 diabetes mellitus who did not always recieve insulin therapy15. ‘Fear’ of hypoglycemica is generally noted to be one of the major barriers to achieving glycemic control16,17, whereas control was required in the studied patients. Strategies to prevent SH, such as education on and talking about SH by physicians and heatlhcare providers, or the use of new agents causing fewer hypoglycemic events, might be effective to reduce fear of hypoglycemia.

Also, age and living alone were associated with fear of hypoglycemia in the present study. Age aggravates fears, such as fear of falling18. Living alone is a risk of coronary heart disease or mortality19,20. Although it might be difficult, as a social action, living with family members and friends could partly contribute to a reduced fear of hypoglycemia.

A strength of the present study was the recruitment of patients at hospitals and clinics nationwide in Japan. Patients who regularly attended the medical facilities were recruited, so they could fully respond to the questionnaire. However, this study had several limitations. The causes of the results cannot be determined because of the cross-sectional nature of the study design. The data were from a self-administered questionnaire, and we did not evaluate objective measures of blood glucose. These limitations should be addressed in future research.

In conclusion, fear of hypoglycemia was associated with SH during the past 1 year, age and living alone in insulin-treated patients with type 2 diabetes mellitus. The results provide important data on fear of hypoglycemia among insulin-treated adult patients with type 2 diabetes mellitus, and show that strategies to lessen the fear of hypoglycemia are required to improve management of the disease.

Acknowledgments

The study was supported by a grant from the National Hospital Organization (multicenter clinical studies) and the Ministry of Health, Welfare and Labor of Japan.

Disclosure

The authors declare no conflict of interest.

References

  • 1.Goto A, Goto M, Noda M, et al. Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis. PLoS ONE. 2013;8:e74699. doi: 10.1371/journal.pone.0074699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Oyer DS. The science of hypoglycemia in patients with diabetes. Curr Diabetes Rev. 2013;9:195–208. doi: 10.2174/15733998113099990059. [DOI] [PubMed] [Google Scholar]
  • 3.Williams SA, Shi L, Brenneman SK, et al. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. J Diabetes Complications. 2012;26:399–406. doi: 10.1016/j.jdiacomp.2012.05.002. [DOI] [PubMed] [Google Scholar]
  • 4.Willis WD, Diago-Cabezudo JI, Madec-Hily A, et al. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res. 2013;13:123–130. doi: 10.1586/erp.12.80. [DOI] [PubMed] [Google Scholar]
  • 5.Ishii H, Furuya M, Ishibashi R, et al. Development of a new questionnaire on glycemic control and its application to insulin-treated patients to investigate the frequency of hypoglycemia and hyperglycemia. J Jpn Diabetes Soc. 2005;48:19–32. (Japanese) [Google Scholar]
  • 6.Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2010;87:64–68. doi: 10.1016/j.diabres.2009.10.013. [DOI] [PubMed] [Google Scholar]
  • 7.Turchin A, Matheny ME, Shubina M, et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32:1153–1157. doi: 10.2337/dc08-2127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Miller ME, Bonds DE, Gerstein HC, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010;340:b5444. doi: 10.1136/bmj.b5444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Nordfeldt S, Ludvigsson J. Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2005;18:83–91. doi: 10.1515/jpem.2005.18.1.83. [DOI] [PubMed] [Google Scholar]
  • 10.Kawamori R, Node K, Hanafusa T, et al. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study. Cardiovasc Diabetol. 2013;12:131. doi: 10.1186/1475-2840-12-131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nakayama K, Yamaguchi K, Maruyama S, et al. Association of smoking with other lifestyle factors and mental health status of Japanese factory workers. Environ Health Prev Med. 1997;2:11–15. doi: 10.1007/BF02931223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ikeda A, Iso H, Toyoshima H, et al. JACC Study Group. Marital status and mortality among Japanese men and women: the Japan Collaborative Cohort Study. BMC Public Health. 2007;7:73. doi: 10.1186/1471-2458-7-73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Johnson SR, Cooper MN, Davis EA, et al. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents. Diabet Med. 2013;30:1126–1131. doi: 10.1111/dme.12247. [DOI] [PubMed] [Google Scholar]
  • 14.Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ. 2011;14:646–655. doi: 10.3111/13696998.2011.610852. [DOI] [PubMed] [Google Scholar]
  • 15.Hajós TR, Polonsky WH, Pouwer F, et al. Toward defining a cutoff score for elevated fear of hypoglycemia on the hypoglycemia fear survey worry subscale in patients with type 2 diabetes. Diabetes Care. 2014;37:102–108. doi: 10.2337/dc13-0971. [DOI] [PubMed] [Google Scholar]
  • 16.Anderbro T, Amsberg S, Adamson U, et al. Fear of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2010;27:1151–1158. doi: 10.1111/j.1464-5491.2010.03078.x. [DOI] [PubMed] [Google Scholar]
  • 17.Moghissi E. Management of type 2 diabetes mellitus in older patients: current and emerging treatment options. Diabetes Ther. 2013;4:239–256. doi: 10.1007/s13300-013-0039-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Uemura K, Shimada H, Makizako H, et al. A lower prevalence of self-reported fear of falling is associated with memory decline among older adults. Gerontology. 2012;58:413–418. doi: 10.1159/000336988. [DOI] [PubMed] [Google Scholar]
  • 19.Molloy GJ, Stamatakis E, Randall G, et al. Marital status, gender and cardiovascular mortality: behavioural, psychological distress and metabolic explanations. Soc Sci Med. 2009;69:223–228. doi: 10.1016/j.socscimed.2009.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Eaker ED, Sullivan LM, Kelly-Hayes M, et al. Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med. 2007;69:509–513. doi: 10.1097/PSY.0b013e3180f62357. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Diabetes Investigation are provided here courtesy of Wiley

RESOURCES